CancerFax

First Global Oncology under MD Anderson Cancer Center provides consultation and referral services for cancer patients

AWritten by Alysha MendossaMedically ReviewedUpdated March 20, 20206 min read
First Global Oncology under MD Anderson Cancer Center provides consultation and referral services for cancer patients
In this article
  1. Expert Cancer Consultation Through MD Anderson Global Channels
  2. How to Access Referrals and International Cancer Treatment
  3. Advancing Global Oncology Research and Medical Training
  4. How CancerFax Helps

Expert Cancer Consultation Through MD Anderson Global Channels

MD Anderson Cancer Center is a global cancer diagnosis and treatment institution. It is a training hospital that countless domestic doctors aspire to. It is also the most hopeful hospital for cancer patients around the world. How to choose the channels to obtain consultation services from American experts is the most important issue for cancer patients ? Global Oncologist Network and the United States MD Anderson Cancer Center’s first Global Oncology Medical Company in cooperation with the United States cancer expert diagnosis and treatment services for patients .

First Global Oncology Medical Co., Ltd. is a joint venture company of MD Anderson Cancer Center in the United States. It has the exclusive patent license of MD Anderson Cancer Center and is the regular channel for consultation and referral of MD Anderson Cancer Center. Based on the cooperation with experts from MD Anderson Cancer Center, First Global Oncology can provide professional treatment planning and consulting services for cancer hospitals and cancer patients, and help cancer patients get consultation opinions from American experts in the country, so that the treatment of cancer patients and the world Hospital synchronization.

How to Access Referrals and International Cancer Treatment

The Global Oncologist Network officially cooperates with First Global Oncology to help cancer patients get expert consultation from MD Anderson Cancer Center. For suitable patients, assist patients to be referred to MD Anderson Cancer Center for treatment. All consultations and referrals were provided by the First Global Oncology Medical Institution, a joint venture company of the MD Anderson Cancer Center in the United States, and went to the Anderson Cancer Center for medical treatment. Patients and doctors who need more information can directly consult the customer service of CancerFax at +91 96 1588 1588.

Our No. 1 Global Oncology Research Center and Service Center is located at the Texas Medical Center, the world’s largest medical center. We join the recognized world cancer center-MD Anderson Cancer Center, invest in and manage cancer centers worldwide, provide the most advanced technical support and quality control services, and jointly build world-class cancer centers and radiotherapy centers.

Advancing Global Oncology Research and Medical Training

We have an expert advisory team of the world’s best and experienced doctors and physicists. Our experts provide remote treatment consultation for cancer patients around the world, and also provide first-class radiotherapy technology services for hospitals at all levels, assisting hospitals to establish advanced radiotherapy quality control models.

With the exclusive authorization of MD Anderson Cancer Center, First Global Oncology is based on a database of clinically-accumulated experts in the most advanced cancer hospitals in the United States, and is backed by web services and high-performance computing platforms. The system has achieved a key breakthrough in the quality and efficiency of clinical precision radiotherapy.

We conduct collaborative research with MD Anderson Cancer Center and other international medical institutions, including the Tianjin Medical University Cancer Hospital, the Chinese Academy of Medical Sciences, etc., with the goal of helping and saving cancer patients worldwide, and constantly developing new anti-cancer technologies.

We provide education and training services for hospitals, doctors and physicists around the world, help medical experts to establish a platform for sharing experience, and promote appropriate and effective diagnostic technologies.

How CancerFax Helps

CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.

description
Medical Record Review

We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.

verified_user
Eligibility Coordination

We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.

hub
Hospital Communication

We support appointment coordination, document submission, translation, and direct communication with international departments.

flight
Travel & Admission Support

For international patients, we help with practical coordination — travel planning, hospital admission guidance, and local support.

explore
Treatment & Trial Navigation

If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.

support_agent
End-to-end Coordination

From inquiry through to follow-up, our coordinators provide a single point of contact for the family.

CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.

AM

About Alysha Mendossa

✓ Reviewed for medical accuracy by the CancerFax review panel.

Medical Disclaimer

This article is for educational purposes only and should not replace medical advice, diagnosis, or treatment from a qualified oncology specialist. Every patient's case is different. Treatment decisions should always be made after a review of complete medical records by the treating medical team.

Treatment availability, eligibility, timelines, and access can change. Any clinical trial participation depends on detailed review and approval by the trial hospital or investigator.